This complaint was first surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign ...
AstraZeneca (AZN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Sachin Jain from Bank ...
Johnson & Johnson said on Tuesday its chemotherapy-free combination treatment showed a meaningful improvement in extending ...
AstraZeneca AZN stock has declined 14% in the past three months. A lot of this price decline is due to ongoing investigations ...
SAN DIEGO, CA / ACCESSWIRE / January 9, 2025 / Robbins LLP reminds investors that a class action was filed on behalf of all ...
Johnson & Johnson’s combination of Rybrevant and Lazcluze has racked up an overall survival (OS) victory against ...
Johnson & Johnson says its bispecific antibody, paired with a Janssen drug, could change treatment for non-small lung cancer ...
As we enter 2025, many growth stocks are trading at high valuations and could be running out of room to rise in the near term ...
Shares of AstraZeneca PLC AZN rose 2.18% to £109.88 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.83% to 8,319.69.
The ADR's fall snapped a three-day winning streak.
IT worker can continue legal battle against pharmaceutical giant after judge rules that impact of skin condition makes him a ...
AstraZeneca has been taking a wider role in Vietnam’s healthcare sector to help expand access to quality healthcare.